Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Forde

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Nature Communications|February 22, 2024
TcrXY is an acid-sensing two-component transcriptional regulator of Mycobacterium tuberculosis required for persistent infectionMiljan Stupar, Lendl Tan, Edward D Kerr, et al.
Veterinary Microbiology|April 9, 2019
Novel insights into pasteurellosis in captive pinnipedsRebecca L Crawford, David Blyde, Patrick J Blackall, et al.
Microbial Genomics|March 10, 2022
Phase variation in the glycosyltransferase genes of <i>Pasteurella multocida</i> associated with outbreaks of fowl cholera on free-range layer farmsLida Omaleki, Patrick J Blackall, Thom Cuddihy, et al.
Plos One|July 19, 2012
Characterization of pro-inflammatory flagellin proteins produced by Lactobacillus ruminis and related motile LactobacilliB Anne Neville, Brian M Forde, Marcus J Claesson, et al.
Microbial Cell Factories|October 15, 2011
Genome sequences and comparative genomics of two Lactobacillus ruminis strains from the bovine and human intestinal tractsBrian M Forde, B Anne Neville, Michelle M O'Donnell, et al.
Plos Genetics|October 24, 2024
Evolution of the pheV-tRNA integrated genomic island in Escherichia coliNguyen Thi Khanh Nhu, Brian M Forde, Nouri L Ben Zakour, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2022
Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibilityAbdulrahman K S Ayfan, Joanne Macdonald, Adam D Irwin, et al.
Antimicrobial Agents and Chemotherapy|May 6, 2026
Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant <i>Escherichia coli</i> using a hollow fiber infection model: a proof-of-concept studyMikaela M Walker, Jason A Roberts, Yixuan Li, et al.
Open Forum Infectious Diseases|October 23, 2025
Snapshot Genomic Surveillance Reveals Insights into Antimicrobial Resistance and Lineage Diversity of Uropathogens in Older Adults in QueenslandBudi Permana, Caitlin Falconer, Johanna Mayer-Coverdale, et al.
Plos Neglected Tropical Diseases|October 12, 2023
Melioidosis Queensland: An analysis of clinical outcomes and genomic factorsIan Gassiep, Delaney Burnard, Budi Permana, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Nature Communications|February 22, 2024
TcrXY is an acid-sensing two-component transcriptional regulator of Mycobacterium tuberculosis required for persistent infectionMiljan Stupar, Lendl Tan, Edward D Kerr, et al.
Veterinary Microbiology|April 9, 2019
Novel insights into pasteurellosis in captive pinnipedsRebecca L Crawford, David Blyde, Patrick J Blackall, et al.
Microbial Genomics|March 10, 2022
Phase variation in the glycosyltransferase genes of <i>Pasteurella multocida</i> associated with outbreaks of fowl cholera on free-range layer farmsLida Omaleki, Patrick J Blackall, Thom Cuddihy, et al.
Plos One|July 19, 2012
Characterization of pro-inflammatory flagellin proteins produced by Lactobacillus ruminis and related motile LactobacilliB Anne Neville, Brian M Forde, Marcus J Claesson, et al.
Microbial Cell Factories|October 15, 2011
Genome sequences and comparative genomics of two Lactobacillus ruminis strains from the bovine and human intestinal tractsBrian M Forde, B Anne Neville, Michelle M O'Donnell, et al.
Plos Genetics|October 24, 2024
Evolution of the pheV-tRNA integrated genomic island in Escherichia coliNguyen Thi Khanh Nhu, Brian M Forde, Nouri L Ben Zakour, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2022
Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibilityAbdulrahman K S Ayfan, Joanne Macdonald, Adam D Irwin, et al.
Antimicrobial Agents and Chemotherapy|May 6, 2026
Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant <i>Escherichia coli</i> using a hollow fiber infection model: a proof-of-concept studyMikaela M Walker, Jason A Roberts, Yixuan Li, et al.
Open Forum Infectious Diseases|October 23, 2025
Snapshot Genomic Surveillance Reveals Insights into Antimicrobial Resistance and Lineage Diversity of Uropathogens in Older Adults in QueenslandBudi Permana, Caitlin Falconer, Johanna Mayer-Coverdale, et al.
Plos Neglected Tropical Diseases|October 12, 2023
Melioidosis Queensland: An analysis of clinical outcomes and genomic factorsIan Gassiep, Delaney Burnard, Budi Permana, et al.
Pageof 9